| 000 | 01726 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515042212.0 | ||
| 264 | 0 | _c20061024 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a1528-395X | ||
| 024 | 7 |
_a10.1016/j.tripleo.2006.06.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuggiero, Salvatore L | |
| 245 | 0 | 0 |
_aBisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. _h[electronic resource] |
| 260 |
_bOral surgery, oral medicine, oral pathology, oral radiology, and endodontics _cOct 2006 |
||
| 300 |
_a433-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aJaw Diseases _xchemically induced |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aOral Surgical Procedures _xadverse effects |
| 650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
| 650 | 0 | 4 |
_aOsteoporosis _xprevention & control |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aFantasia, John | |
| 700 | 1 | _aCarlson, Eric | |
| 773 | 0 |
_tOral surgery, oral medicine, oral pathology, oral radiology, and endodontics _gvol. 102 _gno. 4 _gp. 433-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tripleo.2006.06.004 _zAvailable from publisher's website |
| 999 |
_c16575553 _d16575553 |
||